181 related articles for article (PubMed ID: 33708551)
1. The usefulness of fluorodeoxyglucose-positron emission tomography as a preoperative diagnostic tool for thymic epithelial tumors.
Tatematsu T; Okuda K; Saito Y; Oda R; Sakane T; Yokota K; Endo K; Nakanishi R
Gland Surg; 2021 Feb; 10(2):690-696. PubMed ID: 33708551
[TBL] [Abstract][Full Text] [Related]
2. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
[TBL] [Abstract][Full Text] [Related]
3. Is (18)F-FDG PET useful in predicting the WHO grade of malignancy in thymic epithelial tumors? A meta-analysis.
Treglia G; Sadeghi R; Giovanella L; Cafarotti S; Filosso P; Lococo F
Lung Cancer; 2014 Oct; 86(1):5-13. PubMed ID: 25175317
[TBL] [Abstract][Full Text] [Related]
4. Role of combined 18F-FDG-PET/CT for predicting the WHO malignancy grade of thymic epithelial tumors: a multicenter analysis.
Lococo F; Cesario A; Okami J; Cardillo G; Cavuto S; Tokunaga T; Apolone G; Margaritora S; Granone P
Lung Cancer; 2013 Nov; 82(2):245-51. PubMed ID: 23992878
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of
Nakajo M; Takeda A; Katsuki A; Jinguji M; Ohmura K; Tani A; Sato M; Yoshiura T
Br J Radiol; 2022 Jun; 95(1134):20211050. PubMed ID: 35312337
[TBL] [Abstract][Full Text] [Related]
6. Value of 18F-FDG PET/computed tomography in predicting the simplified WHO grade of malignancy in thymic epithelial tumors.
Zhao J; Wang H; Li Q
Nucl Med Commun; 2020 Apr; 41(4):405-410. PubMed ID: 32032191
[TBL] [Abstract][Full Text] [Related]
7. Combined imaging with 18F-FDG-PET/CT and 111In-labeled octreotide SPECT for evaluation of thymic epithelial tumors.
De Luca S; Fonti R; Palmieri G; Federico P; Del Prete G; Pacelli R; Pace L; De Placido S; Salvatore M; Del Vecchio S
Clin Nucl Med; 2013 May; 38(5):354-8. PubMed ID: 23486323
[TBL] [Abstract][Full Text] [Related]
8. Can
Nakagawa K; Takahashi S; Endo M; Ohde Y; Kurihara H; Terauchi T
Cancer Manag Res; 2017; 9():761-768. PubMed ID: 29263700
[TBL] [Abstract][Full Text] [Related]
9. Distinguishing thymic cysts from low-risk thymomas via [
Choi S; Kim YI; Han S; Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI; Ryu JS
EJNMMI Res; 2024 May; 14(1):45. PubMed ID: 38702532
[TBL] [Abstract][Full Text] [Related]
10. ¹⁸F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival.
Seki N; Sakamoto S; Karube Y; Oyaizu T; Ishihama H; Chida M
Ann Nucl Med; 2014 Apr; 28(3):257-62. PubMed ID: 24430867
[TBL] [Abstract][Full Text] [Related]
11. Tumor immunity is related to
Imai H; Kaira K; Hashimoto K; Nitanda H; Taguchi R; Yanagihara A; Umesaki T; Yamaguchi O; Mouri A; Kawasaki T; Yasuda M; Kobayashi K; Sakaguchi H; Kuji I; Kagamu H
Cancer Med; 2021 Sep; 10(18):6317-6326. PubMed ID: 34363337
[TBL] [Abstract][Full Text] [Related]
12. A diagnostic model based on
Zhou S; Tsui P; Lin M; Chen G; Chen W; Cai X
BMC Med Imaging; 2024 Jan; 24(1):14. PubMed ID: 38191331
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment serum neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios: Two tumor-related systemic inflammatory markers in patients with thymic epithelial tumors.
Wang L; Ruan M; Yan H; Lei B; Sun X; Chang C; Liu L; Xie W
Cytokine; 2020 Sep; 133():155149. PubMed ID: 32512341
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Mediastinal Tumors Using SUV
Morita T; Tatsumi M; Ishibashi M; Isohashi K; Kato H; Honda O; Shimosegawa E; Tomiyama N; Hatazawa J
Asia Ocean J Nucl Med Biol; 2017; 5(1):22-29. PubMed ID: 28840135
[TBL] [Abstract][Full Text] [Related]
15. Fluorodeoxyglucose Positron Emission Tomography Can Provide Useful Information for Differentiating Thymic Epithelial Tumors.
Tomita M; Ayabe T; Tsuchiya K; Nakamura K
Thorac Cardiovasc Surg; 2018 Jun; 66(4):345-349. PubMed ID: 28728209
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic values of 2-[
Han S; Kim YI; Oh JS; Seo SY; Park MJ; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI; Ryu JS
Eur Radiol; 2022 Feb; 32(2):1173-1183. PubMed ID: 34448035
[TBL] [Abstract][Full Text] [Related]
17. Value of 18F-FDG PET/CT for Predicting the World Health Organization Malignant Grade of Thymic Epithelial Tumors: Focused in Volume-Dependent Parameters.
Park SY; Cho A; Bae MK; Lee CY; Kim DJ; Chung KY
Clin Nucl Med; 2016 Jan; 41(1):15-20. PubMed ID: 26545017
[TBL] [Abstract][Full Text] [Related]
18. Impact of
Akamine T; Nakagawa K; Ito K; Watanabe H; Yotsukura M; Yoshida Y; Yatabe Y; Kusumoto M; Watanabe SI
Ann Surg Oncol; 2024 Jan; 31(1):192-200. PubMed ID: 37743455
[TBL] [Abstract][Full Text] [Related]
19. The combination of maximum standardized uptake value and clinical parameters for improving the accuracy in distinguishing primary mediastinal lymphomas from thymic epithelial tumors.
Yan H; Wang L; Lei B; Ruan M; Chang C; Zhou M; Liu L; Xie W; Wang Y
Quant Imaging Med Surg; 2024 Feb; 14(2):1944-1956. PubMed ID: 38415117
[TBL] [Abstract][Full Text] [Related]
20. Differentiating the grades of thymic epithelial tumor malignancy using textural features of intratumoral heterogeneity via (18)F-FDG PET/CT.
Lee HS; Oh JS; Park YS; Jang SJ; Choi IS; Ryu JS
Ann Nucl Med; 2016 May; 30(4):309-19. PubMed ID: 26868139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
